Specific immunotherapy for allergic rhinitis in children
- PMID: 25207858
- DOI: 10.1097/MOO.0000000000000101
Specific immunotherapy for allergic rhinitis in children
Abstract
Purpose of review: Allergic rhinitis is a highly prevalent inflammatory disease affecting 20-40% of the children worldwide. Allergen-specific immunotherapy (SIT) is an effective treatment for allergic rhinitis. This article reviews the recent advances in SIT for children.
Recent findings: In current clinical practice, immunotherapy is delivered as either subcutaneous immunotherapy or sublingual immunotherapy (SLIT). Most meta-analyses and reviews concluded a trend that subcutaneous immunotherapy was better than SLIT in reducing symptoms of allergic rhinitis and rescue medication use, however, SLIT has a better safety profile than subcutaneous immunotherapy. Additionally, the absence of pain on administration of therapy is a character of SLIT, which is well suited for children. T regulatory cells, especially Tr1 cells that secrete interleukin-10 and induce production of immunoglobulin G4, play a role during SIT.
Summary: Although there is substantial evidence for effectiveness of both subcutaneous immunotherapy and SLIT, safer and more effective SIT approaches are needed. New approaches to improve SIT include omalizumab pretreatment, use of recombinant allergens, and alternate routes of administration.
Similar articles
-
Sublingual immunotherapy in children: the recent experiences.Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):582-90. doi: 10.1097/ACI.0000000000000112. Curr Opin Allergy Clin Immunol. 2014. PMID: 25188717 Review.
-
Sublingual or subcutaneous immunotherapy for allergic rhinitis?J Allergy Clin Immunol. 2016 Feb;137(2):339-349.e10. doi: 10.1016/j.jaci.2015.12.1298. J Allergy Clin Immunol. 2016. PMID: 26853126 Review.
-
Clinical efficacy of immunotherapy in allergic rhinitis.Am J Rhinol Allergy. 2016 Sep 1;30(5):4-7. doi: 10.2500/ajra.2016.30.4368. Am J Rhinol Allergy. 2016. PMID: 29025463 Review.
-
Effectiveness of subcutaneous versus sublingual immunotherapy for allergic rhinitis: current update.Curr Opin Otolaryngol Head Neck Surg. 2014 Jun;22(3):211-5. doi: 10.1097/MOO.0000000000000045. Curr Opin Otolaryngol Head Neck Surg. 2014. PMID: 24732432 Review.
-
Clinical efficacy of immunotherapy in allergic rhinitis.Am J Rhinol Allergy. 2016 Sep 1;30(5):4-7. doi: 10.2500/ajra.2016.30.4368. Am J Rhinol Allergy. 2016. PMID: 27658025 Review.
Cited by
-
Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.Allergy Asthma Immunol Res. 2018 Jul;10(4):300-353. doi: 10.4168/aair.2018.10.4.300. Allergy Asthma Immunol Res. 2018. PMID: 29949830 Free PMC article. Review.
-
Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update.Allergy Asthma Immunol Res. 2022 Nov;14(6):604-652. doi: 10.4168/aair.2022.14.6.604. Allergy Asthma Immunol Res. 2022. PMID: 36426395 Free PMC article. Review.
-
Increased Expression of miR-146a in Children With Allergic Rhinitis After Allergen-Specific Immunotherapy.Allergy Asthma Immunol Res. 2016 Mar;8(2):132-40. doi: 10.4168/aair.2016.8.2.132. Epub 2015 Oct 22. Allergy Asthma Immunol Res. 2016. PMID: 26739406 Free PMC article.
-
Chinese Guideline on allergen immunotherapy for allergic rhinitis.J Thorac Dis. 2017 Nov;9(11):4607-4650. doi: 10.21037/jtd.2017.10.112. J Thorac Dis. 2017. PMID: 29268533 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials